Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds
Medcity News,
Nearly a year ago, biotech startup Acelyrin emerged with two industry veterans at the helm, an unspecified amount of funding…
Nearly a year ago, biotech startup Acelyrin emerged with two industry veterans at the helm, an unspecified amount of funding…
. Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases. Front Aging Neurosci.